(Q54287457)

27 May 2018

title

miR-143 inhibits the metastasis of pancreatic cancer and an associated signaling pathway. (English)

1 reference

27 May 2018

1 reference

Yongjun Hu

1

1 reference

27 May 2018

Yanglu Ou

2

1 reference

27 May 2018

Kemin Wu

3

1 reference

27 May 2018

Yuxiang Chen

4

1 reference

27 May 2018

Weijia Sun

5

1 reference

27 May 2018

publication date

16 October 2012

1 reference

27 May 2018

published in

Tumor Biology

1 reference

27 May 2018

volume

33

1 reference

27 May 2018

issue

6

1 reference

27 May 2018

page(s)

1863-1870

1 reference

27 May 2018

https://scigraph.springernature.com/pub.10.1007/s13277-012-0446-8

exact match

0 references

cites work

Looking to the future: biomarkers in the management of pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0446-8

Honokiol arrests cell cycle, induces apoptosis, and potentiates the cytotoxic effect of gemcitabine in human pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0446-8

Major molecular markers in pancreatic ductal adenocarcinoma and their roles in screening, diagnosis, prognosis, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0446-8

Dissemination and growth of cancer cells in metastatic sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0446-8

Metadherin, a cell surface protein in breast tumors that mediates lung metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0446-8

Rho-family GTPases in cadherin-mediated cell-cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0446-8

Cell growth and metastasis in pancreatic cancer: is Vav the Rho'd to activation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0446-8

Guanine nucleotide exchange factors for RhoGTPases: good therapeutic targets for cancer therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0446-8

BRAF and RAS oncogenes regulate Rho GTPase pathways to mediate migration and invasion properties in human colon cancer cells: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0446-8

A microRNA expression signature of human solid tumors defines cancer gene targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0446-8

Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0446-8

RETRACTED: Increased Ras GTPase activity is regulated by miRNAs that can be attenuated by CDF treatment in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0446-8

Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0446-8

Enhancement of hypoxia-induced tumor cell death in vitro and radiation therapy in vivo by use of small interfering RNA targeted to hypoxia-inducible factor-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0446-8

Lysophosphatidic acid (LPA) in malignant ascites stimulates motility of human pancreatic cancer cells through LPA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0446-8

LPA1 receptors mediate stimulation, whereas LPA2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0446-8

Phenotype and genotype of pancreatic cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0446-8

E-cadherin negatively regulates neoplastic growth in non-small cell lung cancer: role of Rho GTPases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0446-8

Matrix metalloproteinases and their clinical relevance in urinary bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0446-8

miR-22 forms a regulatory loop in PTEN/AKT pathway and modulates signaling kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0446-8

Histologic features of venous invasion, expression of vascular endothelial growth factor and matrix metalloproteinase-2 and matrix metalloproteinase-9, and the relation with liver metastasis in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-012-0446-8

Identifying targets of miR-143 using a SILAC-based proteomic approach

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23070684

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A comparison of antiangiogenic therapies for the prevention of liver metastases

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23070684

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Epidermal growth factor receptor inhibition strategies in pancreatic cancer: past, present and the future.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23070684

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S13277-012-0446-8

1 reference

27 May 2018

1 reference

27 May 2018